Marc De Leeuw

Supreme Court Decision on Scope of Patent Protection: Supreme Court Holds Pharmaceutical Treatment Method Without “Inventive” Insight Unpatentable as a Law of Nature
Garrard R. Beeney,Adam R. Brebner,Marc De Leeuw,John Evangelakos,Nader A. Mousavi,Keith A. Pagnani,James T. Williams, March 23, 2012
In a decision that is likely to have significant implications across the healthcare spectrum, including biotech, diagnostics and medical devices, on March 20, 2012, the U.S. Supreme Court held that two patents claiming methods for optimizing the therapeutic efficacy of drugs by monitoring...

The Second Circuit Curbs ERISA “Stock Drop” Class Actions: Following Other Circuits, the Second Circuit Adopts the Moench Presumption of Prudence, Which Limits Liability of ERISA Fiduciaries for Losses Suffered in Employer-Sponsored Retirement Plans
Marc De Leeuw,Robert J. Giuffra,Suhana S. Han,Joseph E. Neuhaus,Richard C. Pepperman,Max J. Schwartz,Jeffrey T. Scott, October 31, 2011
In the wake of the financial crisis, the plaintiffs’ bar has increasingly brought so-called ERISA “stock drop” actions against issuers, particularly financial institutions, that suffered large stock losses. Often brought as “tag alongs” to putative shareholder...

Congress Passes Historic Patent Reform Legislation: America Invents Act Transitions U.S. Patent System from a “First-to-Invent” to “First-Inventor-to-File” System, Overhauls Post-Issue Review Proceedings and Provides Other Significant Reforms; Expected to Become Law by End of September
Garrard R. Beeney,Adam R. Brebner,Marc De Leeuw,David B. Tulchin,James T. Williams, September 21, 2011
On September 8, 2011, the U.S. Senate approved a landmark bill to reform the nation’s patent system, entitled the “Leahy-Smith America Invents Act,” which was previously passed by the U.S. House of Representatives on June 23, 2011. President Obama is expected to sign the bill into...